Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing when to start retirement planning is crucial for a secure future. Gain insights that will help you prepare effectively for retirement.
15,847 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore how Invitation Homes navigated Q4 2025, the drivers behind its earnings, and what savvy investors should watc...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
As earnings season unfolds, fidelity national (fnf) earnings headlines can be complex. This article breaks down the n...
A data center spending surge across AI giants is reshaping markets. This article explains how a single company could ...
One member of the famous seven has slipped 22% from its high. This article outlines whether the drop is a buying sign...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...